Proteome serological determination of tumor-associated antigens in melanoma

PLoS ONE

Volumn 4, Issue 4, 2009, Pages

  Forgber, Michael ^a   Trefzer, Uwe ^a   Sterry, Wolfram ^a   Walden, Peter ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ENOLASE; GALECTIN 3; MELANOMA ANTIGEN; PROTEOME; CANCER ANTIBODY; TUMOR ANTIGEN;

ANTIBODY RESPONSE; ANTIGEN DETECTION; ARTICLE; CANCER INVASION; CARCINOGENESIS; CONTROLLED STUDY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MELANOMA; METASTASIS POTENTIAL; NUCLEOTIDE SEQUENCE; PROTEIN ANALYSIS; PROTEOMICS; BIOSYNTHESIS; BLOOD; IMMUNOLOGY; MASS SPECTROMETRY; TUMOR CELL LINE; TWO DIMENSIONAL GEL ELECTROPHORESIS; WESTERN BLOTTING;

ANTIBODIES, NEOPLASM; ANTIGENS, NEOPLASM; BLOTTING, WESTERN; CELL LINE, TUMOR; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; HUMANS; MELANOMA; PROTEOME; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 65449178787     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0005199     Document Type: Article

References (51)

1. Chen YT, Stockert E, Jungbluth A, Tsang S, Coplan KA, et al. (1996) Serological analysis of Melan-A(MART-1), a melanocyte-specific protein homogeneously expressed in human melanomas. Proc Natl Acad Sci USA 93: 5915-5919.
2. Rattner JB, Rees J, Whitehead CM, Casiano CA, Tan EM, et al. (1997) High frequency of neoplasia in patients with autoantibodies to centromere protein CENP-F. Clin Invest Med 20: 308-319.
3. Gure AO, Stockert E, Arden KC, Boyer AD, Viars CS, et al. (2000) CT10, a new cancer-testis (CT) antigen homologous to CT7 and the MAGE family, identified by representational-difference analysis. Int J Cancer 1285: 726-732.
4. Kellner R, Lichtenfels R, Atkins D, Bukur J, Ackermann A, et al. (2002) Targeting of tumor associated antigens in renal cell carcinoma using proteome-based analysis and their clinical significance. Proteomics 2: 1743-1751.
5. Usener D, Gerhardt A, Schadendorf D, Eichmuller S (2003) Seroreactivity against MAGE-A and LAGE-1 proteins in melanoma patients. Br J Dermatol 149: 282-288.
6. Neumann F, Wagner C, Kubuschok B, Stevanovic S, Rammensee HG, et al. (2004) Identification of an antigenic peptide derived from the cancer-testis antigen NY-ESO-1 binding to a broad range of HLA-DR subtypes. Cancer Immunol Immunother 53: 589-599.
7. Ehlken H, Schadendorf D, Eichmuller S (2004) Humoral immune response against melanoma antigens induced by vaccination with cytokine gene-modified autologous tumor cells. Int J Cancer 108: 307-313.
8. Zippelius A, Gati A, Bartnick T, Walton S, Odermatt B, et al. (2007) Melanocyte differentiation antigen RAB38/NY-MEL-1 induces frequent antibody responses exclusively in melanoma patients. Cancer Immunol Immunother 56: 249-258.
9. Tureci O, Sahin U, Schobert I, Koslowski M, Scmitt H, et al. (1996) The SSX-2 gene, which is involved in the t(X;18) translocation of synovial sarcomas, codes for the human tumor antigen HOM-MEL-40. Cancer Res 56: 4766-4772.
10. Chen YT, Scanlan MJ, Sahin U, Tureci O, Gure AO, et al. (1997) A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening. Proc Natl Acad Sci USA 94: 1914-1918.
11. Jager D, Stockert E, Jager E, Gure AO, Scanlan MJ, et al. (2000) Serological cloning of a melanocyte rab guanosine 5′-triphosphate-binding protein and a chromosome condensation protein from a melanoma complementary DNA library. Cancer Res 60: 3584-3591.
12. Hartmann TB, Bazhin AV, Schadendorf D, Eichmuller SB (2005) SEREX identification of new tumor antigens linked to melanoma-associated retinopathy. Int J Cancer 114: 88-93.
13. Chen YT, Gure AO, Tsang S, Stockert E, Jager E, et al. (1998) Identification of multiple cancer/testis antigens by allogeneic antibody screening of a melanoma cell line library. Proc Natl Acad Sci USA 95: 6919-6923.
14. Bacarese-Hamilton T, Bistoni F, Crisanti A (2002) Protein microarrays, from serodiagnosis to whole proteome scale analysis of the immune response against pathogenic microorganisms. Biotechniques Suppl: 24-29.
15. De Monte L, Sanvito F, Olivieri S, Viganò F, Doglioni C, et al. (2008) Serological immunoreactivity against colon cancer proteome varies upon disease progression. J Proteome Res 7: 504-14.
16. Jungblut PR, Bumann D (2002) Immunoproteome of Helicobacter pylori. Methods Enzymol 358: 307-316.
17. Unwin RD, Harnden P, Pappin D, Rahman D, Whelan P, et al. (2003) Serological and proteomic evaluation of antibody responses in the identification of tumor antigens in renal cell carcinoma. Proteomics 3: 45-55.
18. Shoshan SH, Admon A (2007) Novel technologies for cancer biomarker discovery, humoral proteomics. Cancer Biomark 3: 141-152.
19. Philip R, Murthy S, Krakover J, Sinnathamby G, Zerfass J (2007) Shared immunoproteome for ovarian cancer diagnostics and immunotherapy, potential theranostic approach to cancer. J Proteome Res 6: 2509-2517.
20. Tomaino B, Cappello P, Capello M, Fredolini C, Ponzetto A, et al. (2007) Autoantibody signature in human ductal pancreatic adenocarcinoma. J Proteome Res 6: 4025-4031.
21. Hardouin J, Lasserre JP, Sylvius L, Joubert-Caron R, Caron M (2007) Cancer immunomics, from serological proteome analysis to multiple affinity protein profiling. Ann N Y Acad Sci 1107: 223-230.
22. Caron M, Choquet-Kastylevsky G, Joubert-Caron R (2007) Cancer immunomics using autoantibody signatures for biomarker discovery. Mol Cell Proteomics 6: 1115-1122.
23. Li C, Xiao Z, Chen Z, Zhang X, Li J, et al. (2006) Proteome analysis of human lung squamous carcinoma. Proteomics 6: 547-558.
24. Lichtenfels R, Kellner R, Atkins D, Bukur J, Ackermann A, et al. (2003) Identification of metabolic enzymes in renal cell carcinoma utilizing PROTEOMEX analyses. Biochim Biophys Acta 1646: 21-31.
25. Looi KS, Nakayasu ES, Diaz RA, Tan EM, Almeida IC, et al. (2008) Using proteomic approach to identify tumor-associated antigens as markers in hepatocellular carcinoma. J Proteome Res 7: 4004-4012.
26. Mobley JA, Lam YW, Lau KM, Pais VM, L'Esperance JO, et al. (2004) Monitoring the serological proteome, the latest modality in prostate cancer detection. J Urol 172: 331-337.
27. Krah A, Jungblut PR (2004) Immunoproteomics. Methods Mol Med 94: 19-32.
28. Uhlen M, Ponten F (2005) Antibody-based proteomics for human tissue profiling. Mol Cell Proteomics 4: 384-393.
29. Yang F, Xiao ZQ, Zhang XZ, Li C, Zhang PF, et al. (2007) Identification of tumor antigens in human lung squamous carcinoma by serological proteome analysis. J Proteome Res 6: 751-758.
30. Gunawardana CG, Diamandis EP (2007) High throughput proteomic strategies for identifying tumour-associated antigens. Cancer Lett 249: 110-119.
31. Forgber M, Basu R, Roychoudhury K, Theinert S, Roy S, et al. (2006) Mapping the antigenicity of the parasites in Leishmania donovani infection by proteome serology. PLoS ONE 1: e40.
32. Li C, Tan YX, Zhou H, Ding SJ, Li SJ, et al. (2005) Proteomic analysis of hepatitis B virus-associated hepatocellular carcinoma: Identification of potential tumor markers. Proteomics 5: 1125-1139.
33. Craven RA, Stanley AJ, Hanrahan S, Dods J, Unwin R, et al. (2006) Proteomic analysis of primary cell lines identifies protein changes present in renal cell carcinoma. Proteomics 6: 2853-2864.
34. Lee M, Kistler C, Hartmann TB, Li F, Dummer R, Dippel E, et al. (2007) Immunoscreening of a cutaneous T-cell lymphoma library for plasma membrane proteins. Cancer Immunol Immunother 56: 783-795.
35. Hartmann TB, Mattern E, Wiedemann N, van Doorn R, Willemze R, et al. (2008) Identification of selectively expressed genes and antigens in CTCL. Exp Dermatol 17: 324-334.
36. Califice S, Castronovo V, Van Den Brule F (2004) Galectin-3 and cancer. Int J Oncol 25: 983-992.
37. Shimura T, Takenaka Y, Fukumori T, Tsutsumi S, Okada K, et al. (2005) Implication of galectin-3 in Wnt signaling. Cancer Res 65: 3535-3537.
38. Nakahara S, Oka N, Raz A (2005) On the role of galectin-3 in cancer apoptosis. Apoptosis 10: 267-275.
39. Zubieta MR, Furman D, Barrio M, Bravo AI, Domenichini E, et al. (2006) Galectin-3 expression correlates with apoptosis of tumor-associated lymphocytes in human melanoma biopsies. Am J Pathol 168: 1666-1675.
40. Vereecken P, Heenen M (2006) Serum galectin-3 in advanced melanoma patients, a hypothesis on a possible role in melanoma progression and inflammation. J Int Med Res 34: 119-120.
41. Pocza P, Süli-Vargha H, Darvas Z, Falus A (2008) Locally generated VGVAPG and VAPG elastin-derived peptides amplify melanoma invasion via the galectin-3 receptor. Int J Cancer 122: 1972-1980.
42. Gunning AP, Bongaerts RJ, Morris VJ (2008) Recognition of galactan components of pectin by galectin-3. FASEB J [fj.08-106617v2.pdf].
43. Mourad-Zeidan AA, Melnikova VO, Wang H, Raz A, Bar-Eli M (2008) Expression profiling of Galectin-3-depleted melanoma cells reveals its major role in melanoma cell plasticity and vasculogenic mimicry. Am J Pathol 173: 1839-1852.
44. Kim JW, Dang CV (2005) Multifaceted roles of glycolytic enzymes. Trends Biochem Sci 30: 142-150.
45. Cui JW, Li WH, Wang J, Li AL, Li HY, et al. (2005) Proteomics-based identification of human acute leukemia antigens that induce humoral immune response. Mol Cell Proteomics 4: 1718-1724.
46. Demine R, Walden P (2004) Sequit: Software for de novo peptide sequencing by matrix-assisted laser desorption/ionization post-source decay mass spectrometry. Rapid Communications in Mass Spectrometry 18: 907-913.
47. Ghoshal A, Mukhopadhyay S, Demine R, Forgber M, Jarmalavicius S, et al. (2009) Detection and characterization of a sialoglycosylated bacterial ABC-type phosphate transporter protein from patients with visceral Leishmaniasis. Glycoconjugate J; DOI 10.1007/s10719-008-9223-8.
48. Gorg A, Postel W, Gunther S (1988) The current state of two-dimensional electrophoresis with immobilized pH gradients. Electrophoresis 9: 531-546.
49. Chan C, Warlow RS, Chapuis PH, Newland RC, Bokey EL (1999) Immobiline-based two-dimensional gel electrophoresis, an optimised protocol for resolution of human colonic mucosal proteins. Electrophoresis 20: 3467-3471.
50. Blum H, Beier H, Gross HJ (1987) Improved silver staining of plant proteins, RNA and DNA in polyacrylamide gels. Electrophoresis 8: 93-99.
51. Gharahdaghi F, Weinberg CR, Meagher DA, Imai BS, Mische SM (1999) Mass spectrometric identification of proteins from silver-stained polyacrylamide gel, a method for the removal of silver ions to enhance sensitivity. Electrophoresis 20: 601-605.